Long Read Sequencing Market Economic, Consumer and Industry Trends for 2028 By Oxford Nanopore Technologies; Tataa Biocenter; Illumina, Inc; Perkinelmer Inc.; F. Hoffmann-La Roche Ltd.; Baseclear B.V.; Bionano Genomics; Longas Technologies; Pacific Biosci

According to the latest study on “Long Read Sequencing Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Technology, Product, Application, Workflow, and End User,” the market was valued at US$ 1,101.15 million in 2020 and it is projected to reach US$ 5,334.68 million by 2028; it is expected to grow at a CAGR of 22.3% during 2021–2028. The report highlights trends prevailing in the global market, and drivers and restraints pertaining to the market growth. Factors such as the advantages of long read sequencing and increasing prevalence of chronic diseases fuel the growth of the long read sequencing market. However, the lack of skilled professionals hinders the market growth.

Request Sample Copy of Long Read Sequencing Market at:
https://www.theinsightpartners.com/sample/TIPRE00006815/?openpr-10225

Based on technology, the long read sequencing market is segmented into single-molecule real-time sequencing (SMRT), nanopore sequencing, and loop genomics long read sequencing. In 2020, the single-molecule real time sequencing (SMRT) segment accounted for the largest share of the market.

Oxford Nanopore Technologies; Tataa Biocenter; Illumina, Inc; Perkinelmer Inc.; F. Hoffmann-La Roche Ltd.; Baseclear B.V.; Bionano Genomics; Longas Technologies; Pacific Biosciences of California, Inc.; and Quantapore, Inc are among the key players operating in the long read sequencing market. These companies focus on partnerships, mergers, product launches, and collaborations to sustain their positions in the market. For instance, in January 2021, Illumina Announced new sequencing system, collaboration with Roche, and software suite to accelerate genomics adoption. Furthermore, Roche will work with Illumina to add additional companion diagnostic (CDx) statements to Illumina's robust pan-cancer assay TruSight Oncology 500 (TSO 500). Moreover, in March 2021, The Oxford Nanopore Ultra-Long DNA Sequencing Kit, when used in conjunction with Circulomics Nanobind Kits, is designed to maximise the number of ultra-long reads and has allowed the continuous sequencing of single DNA fragments of up to 3+ Mb externally and 4+ Mb internally. Using this method, users can achieve more than 100 reads over 1 Mb per PromethION flow cell run.

The report segments the global long read sequencing market as follows:

By Technology

Single-Molecule Real-Time Sequencing (SMRT)
Nanopore Sequencing
Loop Genomics Long Read Sequencing

By Product

Instruments
Consumables
Services

By Application

Identification and Fine Mapping of Structural Variation
Tandem Repeat Sequencing
Pseudogene Discrimination
Resolving Allele Phasing
Reproductive Genomics
Cancer
Viral and Microbial Sequencing
Others

By Workflow

Pre-sequencing
Sequencing
Data Analysis

By End User

Academic Research Institutes
Hospitals and Clinics
Pharma and Biotechnology Companies

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
Italy
UK
Italy
Asia Pacific
China
India
South Korea
Japan
Australia
Middle East and Africa
South Africa
Saudi Arabia
UAE
South and Central America
Brazil
Argentina

Interested in purchasing Long Read Sequencing Research Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00006815/?openpr-10225

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

This release was published on openPR.